Webinar | August 11, 2023

What's Really In The Box? Characterizing AAV Encapsidated Nucleic Acid Sequences Using NGS

Due to the nature of AAV particle production, non-targeted sequences may be packaged along with the gene of interest. Even in an optimized system, these non-target nucleic acids could constitute between 1-2% or greater of the entire nucleic acid payload. It is crucial to properly characterize these non-targeted sequences that may be enclosed within the vector, as this is vital for ensuring the safety profile of the end product.

Next-generation sequencing (NGS) offers a more comprehensive insight into the complete range of encapsidated sequences within AAV particles. Here, we discuss the characterization of several representative AAV molecules using NGS, including the sequencing process, bioinformatic analysis, and representative results.

access the Webinar!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma